Katharine Cheng

1.2k total citations
20 papers, 860 citations indexed

About

Katharine Cheng is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Microbiology. According to data from OpenAlex, Katharine Cheng has authored 20 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 5 papers in Surgery and 5 papers in Microbiology. Recurrent topics in Katharine Cheng's work include Cystic Fibrosis Research Advances (13 papers), Reproductive tract infections research (5 papers) and Neonatal Respiratory Health Research (5 papers). Katharine Cheng is often cited by papers focused on Cystic Fibrosis Research Advances (13 papers), Reproductive tract infections research (5 papers) and Neonatal Respiratory Health Research (5 papers). Katharine Cheng collaborates with scholars based in United Kingdom, Pakistan and United States. Katharine Cheng's co-authors include Deborah Ashby, Rosalind L. Smyth, Rosalind L Smyth, David Heaf, Catherine Doherty, Hendrik van Saene, Craig Winstanley, C. Anthony Hart, John R. W. Govan and Ih Chang and has published in prestigious journals such as The Lancet, Cochrane Database of Systematic Reviews and American Journal of Ophthalmology.

In The Last Decade

Katharine Cheng

20 papers receiving 834 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katharine Cheng United Kingdom 15 496 184 167 161 156 20 860
Douglas B. Hornick United States 19 465 0.9× 265 1.4× 287 1.7× 242 1.5× 109 0.7× 36 1.1k
T. Pressler Denmark 19 784 1.6× 210 1.1× 399 2.4× 115 0.7× 29 0.2× 56 1.3k
J Wedgwood Switzerland 12 241 0.5× 94 0.5× 361 2.2× 156 1.0× 267 1.7× 13 766
Carl Kamme Sweden 22 302 0.6× 108 0.6× 552 3.3× 130 0.8× 250 1.6× 54 1.3k
Ganapathi I. Parameswaran United States 12 325 0.7× 132 0.7× 436 2.6× 53 0.3× 181 1.2× 19 918
Véronique Houdouin France 15 143 0.3× 50 0.3× 156 0.9× 128 0.8× 42 0.3× 45 654
Alexa A. Pragman United States 17 597 1.2× 672 3.7× 224 1.3× 23 0.1× 69 0.4× 29 1.4k
Tetsuji Aoyagi Japan 19 87 0.2× 210 1.1× 280 1.7× 180 1.1× 65 0.4× 64 1.1k
Tadatoshi Kuratsuji Japan 20 93 0.2× 337 1.8× 287 1.7× 207 1.3× 23 0.1× 72 1.2k
Stephen W. Schwarzmann United States 8 153 0.3× 137 0.7× 323 1.9× 40 0.2× 35 0.2× 9 640

Countries citing papers authored by Katharine Cheng

Since Specialization
Citations

This map shows the geographic impact of Katharine Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katharine Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katharine Cheng more than expected).

Fields of papers citing papers by Katharine Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katharine Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katharine Cheng. The network helps show where Katharine Cheng may publish in the future.

Co-authorship network of co-authors of Katharine Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Katharine Cheng. A scholar is included among the top collaborators of Katharine Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katharine Cheng. Katharine Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Katharine, Deborah Ashby, & Rosalind L. Smyth. (2017). Ursodeoxycholic acid for cystic fibrosis-related liver disease. Cochrane Database of Systematic Reviews. 2021(4). CD000222–CD000222. 71 indexed citations
2.
Cheng, Katharine, Deborah Ashby, & Rosalind L. Smyth. (2015). Oral steroids for long-term use in cystic fibrosis. Cochrane Database of Systematic Reviews. 2021(4). CD000407–CD000407. 44 indexed citations
3.
Cheng, Katharine, Deborah Ashby, & Rosalind L. Smyth. (2014). Ursodeoxycholic acid for cystic fibrosis-related liver disease. Cochrane Database of Systematic Reviews. CD000222–CD000222. 18 indexed citations
4.
Cheng, Katharine, Deborah Ashby, & Rosalind L. Smyth. (2013). Oral steroids for long-term use in cystic fibrosis. Cochrane Database of Systematic Reviews. CD000407–CD000407. 19 indexed citations
5.
Cheng, Katharine, Deborah Ashby, & Rosalind L. Smyth. (2012). Ursodeoxycholic acid for cystic fibrosis-related liver disease. Cochrane Database of Systematic Reviews. 10. CD000222–CD000222. 21 indexed citations
6.
Cheng, Katharine, Deborah Ashby, & Rosalind L. Smyth. (2011). Oral steroids for long-term use in cystic fibrosis. Cochrane Database of Systematic Reviews. CD000407–CD000407. 13 indexed citations
7.
Cheng, Katharine, et al.. (2000). Randomized controlled trials in cystic fibrosis (1966-1997) categorized by time, design, and intervention. Pediatric Pulmonology. 29(1). 1–7. 37 indexed citations
8.
Cheng, Katharine, et al.. (2000). Randomized controlled trials in cystic fibrosis (1966–1997) categorized by time, design, and intervention. Pediatric Pulmonology. 29(1). 1–7. 4 indexed citations
9.
Cheng, Katharine, Deborah Ashby, & Rosalind L. Smyth. (1999). Ursodeoxycholic acid for cystic fibrosis-related liver disease. Cochrane Database of Systematic Reviews. CD000222–CD000222. 43 indexed citations
10.
Cheng, Katharine, Deborah Ashby, & Rosalind L. Smyth. (1999). Oral steroids for cystic fibrosis. Cochrane Database of Systematic Reviews. CD000407–CD000407. 52 indexed citations
11.
Smyth, Rosalind L., et al.. (1998). Systematic reviews in cystic fibrosis. Journal of the Royal Society of Medicine. 91(34_suppl). 19–24. 2 indexed citations
12.
Cheng, Katharine, et al.. (1998). Time to publication as full reports of abstracts of randomized controlled trials in cystic fibrosis. Pediatric Pulmonology. 26(2). 101–105. 33 indexed citations
13.
Peters, Ove A., et al.. (1997). Randomised controlled trial of acetate in preterm neonates receiving parenteral nutrition. Archives of Disease in Childhood Fetal & Neonatal. 77(1). F12–F15. 24 indexed citations
14.
Cheng, Katharine, Deborah Ashby, & Rosalind L Smyth. (1997). Ursodeoxycholic Acid in Cystic Fibrosis-Related Liver Disease: A Systematic Review. Journal of the Royal Society of Medicine. 90(31_suppl). 6–12. 11 indexed citations
15.
Cheng, Katharine, Rosalind L Smyth, John R. W. Govan, et al.. (1996). Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. The Lancet. 348(9028). 639–642. 319 indexed citations
16.
Woolridge, R. L., et al.. (1967). Failure of Trachoma Treatment with Ophthalmic Antibiotics and Systemic Sulfonamides Used Alone or in Combination with Trachoma Vaccine. American Journal of Ophthalmology. 63(5). 1577–1583. 15 indexed citations
17.
Woolridge, R. L., et al.. (1967). Long-Term Follow-Up of the Initial (1959–1960) Trachoma Vaccine Field Trial on Taiwan. American Journal of Ophthalmology. 63(5). 1650–1653. 33 indexed citations
18.
Woolridge, R. L., et al.. (1967). Field Trial of A Monovalent and of A Bivalent Mineral Oil Adjuvant Trachoma Vaccine in Taiwan School Children. American Journal of Ophthalmology. 63(5). 1645–1650. 44 indexed citations
19.
Perrin, Edward B., et al.. (1967). Natural History of Trachoma in Taiwan School Children. American Journal of Ophthalmology. 63(5). 1313–1320. 11 indexed citations
20.
Grayston, J. Thomas, et al.. (1963). Field Studies of Protection from Infection by Experimental Trachoma Virus Vaccine in Preschool-Aged Children on Taiwan.. Experimental Biology and Medicine. 112(3). 589–595. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Douglas B. Hornick Breakdown of academic impact, for papers by T. Pressler Breakdown of academic impact, for papers by J Wedgwood Breakdown of academic impact, for papers by Carl Kamme Breakdown of academic impact, for papers by Ganapathi I. Parameswaran Breakdown of academic impact, for papers by Véronique Houdouin Breakdown of academic impact, for papers by Alexa A. Pragman Breakdown of academic impact, for papers by Tetsuji Aoyagi Breakdown of academic impact, for papers by Tadatoshi Kuratsuji Breakdown of academic impact, for papers by Stephen W. Schwarzmann
Rankless by CCL
2026